OTCMKTS:ATTBF

Abattis Bioceuticals Competitors

$0.02
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.02
$0.03
52-Week Range
$0.00
Now: $0.02
$0.08
Volume267,821 shs
Average Volume1.29 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Abattis Bioceuticals (OTCMKTS:ATTBF) Vs. DDXS, TNGN, ADTX, AGNPF, LBTSF, and CBDC

Should you be buying ATTBF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Abattis Bioceuticals, including (DDXS) (DDXS), (TNGN) (TNGN), ADiTx Therapeutics (ADTX), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), and Apotheca Biosciences (CBDC).

Abattis Bioceuticals (OTCMKTS:ATTBF) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Profitability

This table compares Abattis Bioceuticals and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
(DDXS)N/AN/AN/A

Analyst Recommendations

This is a summary of current recommendations and price targets for Abattis Bioceuticals and (DDXS), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
(DDXS)0000N/A

Valuation & Earnings

This table compares Abattis Bioceuticals and (DDXS)'s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
(DDXS)N/AN/AN/AN/AN/A

(TNGN) (OTCMKTS:TNGN) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both health technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares (TNGN) and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Valuation and Earnings

This table compares (TNGN) and Abattis Bioceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for (TNGN) and Abattis Bioceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Abattis Bioceuticals0000N/A

Abattis Bioceuticals (OTCMKTS:ATTBF) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

Profitability

This table compares Abattis Bioceuticals and ADiTx Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/A

Earnings and Valuation

This table compares Abattis Bioceuticals and ADiTx Therapeutics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
ADiTx TherapeuticsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations and price targets for Abattis Bioceuticals and ADiTx Therapeutics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
ADiTx Therapeutics00103.00

Summary

ADiTx Therapeutics beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Algernon Pharmaceuticals (OTCMKTS:AGNPF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, risk, valuation, profitability, dividends, analyst recommendations and institutional ownership.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Algernon Pharmaceuticals and Abattis Bioceuticals, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Algernon Pharmaceuticals0000N/A
Abattis Bioceuticals0000N/A

Profitability

This table compares Algernon Pharmaceuticals and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Algernon PharmaceuticalsN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Earnings & Valuation

This table compares Algernon Pharmaceuticals and Abattis Bioceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Algernon PharmaceuticalsN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Almirall (OTCMKTS:LBTSF) and Abattis Bioceuticals (OTCMKTS:ATTBF) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Analyst Recommendations

This is a summary of current ratings for Almirall and Abattis Bioceuticals, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Almirall01102.50
Abattis Bioceuticals0000N/A

Profitability

This table compares Almirall and Abattis Bioceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AlmirallN/AN/AN/A
Abattis BioceuticalsN/AN/AN/A

Earnings and Valuation

This table compares Almirall and Abattis Bioceuticals' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AlmirallN/AN/AN/AN/AN/A
Abattis BioceuticalsN/AN/AN/AN/AN/A

Summary

Almirall beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Abattis Bioceuticals (OTCMKTS:ATTBF) and Apotheca Biosciences (NASDAQ:CBDC) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Profitability

This table compares Abattis Bioceuticals and Apotheca Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
Apotheca BiosciencesN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Abattis Bioceuticals and Apotheca Biosciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
Apotheca Biosciences0000N/A

Valuation & Earnings

This table compares Abattis Bioceuticals and Apotheca Biosciences' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
Apotheca BiosciencesN/AN/AN/AN/AN/A


Abattis Bioceuticals Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
ADiTx Therapeutics logo
ADTX
ADiTx Therapeutics
1.0$2.57flat$0.00N/A0.00Gap Up
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.13flat$0.00N/A0.00Increase in Short Interest
Almirall logo
LBTSF
Almirall
0.5$15.00flat$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.07flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.01flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
Avid Bioservices logo
CDMOP
Avid Bioservices
0.3$25.06flat$0.00N/A0.00News Coverage
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00Gap Up
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.52flat$0.00N/A0.00
BMEA
Biomea Fusion
0.0N/AN/A$0.00N/A0.00Upcoming Earnings
High Trading Volume
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.18flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.03flat$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$23.32flat$0.00N/A0.00Decrease in Short Interest
News Coverage
CELZ
Creative Medical Technology
0.5$0.04flat$0.00N/A0.00
Cybin logo
CLXPF
Cybin
1.0$1.40flat$0.00N/A0.00
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.12flat$0.00N/A0.00High Trading Volume
News Coverage
Gap Down
GB Sciences logo
GBLX
GB Sciences
0.5$0.05flat$0.00N/A0.00Increase in Short Interest
Gap Down
Genfit logo
GNFTF
Genfit
0.5$4.52flat$0.00N/A0.00Decrease in Short Interest
GMXAY
GENMAB A/S/S
0.5$35.23flat$0.00N/A0.00High Trading Volume
Genus logo
GENSF
Genus
0.7$69.40flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
HALB
Halberd
0.0$0.04flat$0.00N/A0.00Gap Down
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.57flat$0.00N/A0.00Decrease in Short Interest
Idorsia logo
IDRSF
Idorsia
0.5$27.18flat$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5N/AN/A$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.26flat$0.00N/A0.00Gap Down
Kalytera Therapeutics logo
KALTF
Kalytera Therapeutics
0.6$0.05flat$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00flat$0.00N/A0.00Gap Up
Mesoblast logo
MEOBF
Mesoblast
0.5$1.73flat$0.00N/A0.00
MCURF
Mind Cure Health
0.0$0.32flat$0.00N/A0.00Increase in Short Interest
Gap Down
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$2.45flat$0.00N/A0.00
Molecular Partners logo
MLLCF
Molecular Partners
0.5$25.70flat$0.00N/A0.00News Coverage
MPSYF
MorphoSys
0.0$92.50flat$0.00N/A0.00Gap Down
NRNVF
Nordic Nanovector ASA
0.0$1.64flat$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$64.87flat$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.05flat$0.00N/A0.00Increase in Short Interest
Oxurion logo
TBGNF
Oxurion
0.5$2.94flat$0.00N/A0.00News Coverage
Gap Down
Pharnext logo
PNEXF
Pharnext
0.0$4.11flat$0.00N/A0.00
PTEO
Proteo
0.5$179.80flat$0.00N/A0.00Gap Down
PROT
Proteonomix
0.5$0.01flat$0.00N/A0.00Increase in Short Interest
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.18flat$0.00N/A0.00High Trading Volume
Decrease in Short Interest
Gap Down
PureTech Health logo
PTCHF
PureTech Health
0.0$5.71flat$0.00N/A0.00Decrease in Short Interest
News Coverage
RCPHF
Recipharm AB (publ)
1.0$16.05flat$0.00N/A0.00High Trading Volume
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.